Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Taxes on Income (Tables)

v3.20.2
Taxes on Income (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets
    As of December, 31  
Composition of deferred tax assets:   2019     2018  
Net operating loss carry-forward   $ 1,585,272     $ 991,987  
Research and development credits     112,149       63,439  
Others     8,556       2,946  
Net deferred tax asset before valuation allowance     1,705,976       1,058,371  
Valuation allowance     (1,705,976 )     (1,058,371 )
Net deferred tax assets   $ -     $ -  

Schedule of Reconcile the Statutory Income Tax Rate to Effective Income Tax Rate
    Year Ended December 31,  
    2019     2018     2017  
                   
Tax rate     23 %     23 %     24 %
                         
Tax expense (benefit) at statutory rate   $ 2,054,113     $ 105,234     $ 642,090  
Tax rate differential     -       -       28,057  
Change in taxes from permanent differences in stock-based compensation     639,504       10,964       27,301  
Change in taxes from permanent difference in derivative warrants liabilities and convertible loans     858,307       (212,959 )     304,254  
Change in temporary differences     111,480       -       -  
Others     1,925       -       -  
Loss carryforwards     442,897       307,229       282,478  
Income tax expense (benefit)   $ -     $ -     $ -